ClinicalTrials.Veeva

Menu

Trial of Non Invasive Ventilation for Respiratoy Distress Syndrome

I

Instituto Materno Infantil Prof. Fernando Figueira

Status

Completed

Conditions

Prematurity
Respiratory Distress Syndrome

Treatments

Device: nasal intermittent positive pressure ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT00821119
IMIP123

Details and patient eligibility

About

The purpose of this study is to evaluate the hypothesis that nasal intermittent positive pressure(NIPP), used as a primary mode of ventilation in preterm infants with RDS, will decrease the need for conventional endotracheal ventilation when compared to nasal continuous positive airway pressure.(NCPAP)

Full description

Respiratory distress syndrome(RDS) and its sequelae, bronchopulmonary dysplasia(BPD) are complications of prematurity.The pathogenesis of BPD is multifactorial and one of the most important risk factors is the ventilator-induced lung injury caused by invasive respiratory support.

The two modes of non-invasive ventilation, NIPP and specially NCPAP, have been used frequently in the respiratory care of preterm infants in neonatal units.NCPAP is currently a common practice for the treatment of RDS . NIPP has been found to be more effective than NCPAP in apnea of prematurity and immediately after extubation in preterm infants,decreasing the need of endotracheal ventilation.

Alternative techniques of non-invasive ventilation has been suggested in some studies to decrease respiratory morbidities associated with prematurity.This non-invasive approach could be used initially as a primary mode of ventilation for infants with RDS in a effort to decrease lung injury and BPD.Studies are needed to compare the effectiveness of these therapies.

Enrollment

200 patients

Sex

All

Ages

1 to 1 day old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • preterm infants with RDS
  • assigned to non invasive ventilation

Exclusion criteria

  • preterm on endotracheal ventilation
  • severe congenital pulmonary or cardiovascular malformation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

NCPAP
Active Comparator group
Description:
preterm infants with nasal positive pressure ventilation as a primary mode of respiratory support in preterm infants with respiratory distress syndrome will be compared to preterm infants with nasal intermittent positive pressure ventilation
Treatment:
Device: nasal intermittent positive pressure ventilation
NIPPV
Experimental group
Description:
preterm with nasal intermittent positive pressure ventilation as a primary mode of respiratory support in preterm infants with respiratory distress syndrome
Treatment:
Device: nasal intermittent positive pressure ventilation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems